Devaki Shilpa Surasi, MBBS, CMQ
Department of Nuclear Medicine, Division of Diagnostic Imaging
Present Title & Affiliation
Primary Appointment
Associate Professor, Department of Nuclear Medicine, Division of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Associate Professor, Department of Diagnostic and Interventional Imaging, Division of Diagnostic Imaging, McGovern Medical School, Houston, TX
Education & Training
Degree-Granting Education
| 2006 | Gandhi Medical College affiliated with NTR University of Health Sciences, Hyderabad, IND, MBBS, Medicine and Surgery |
Postgraduate Training
| 2015-2018 | Clinical Residency, Diagnostic Radiology, The University of Oklahoma Health Sciences, Oklahoma City, OK |
| 2012-2015 | Clinical Residency, Clinical Nuclear Medicine, University of Alabama at Birmingham, Birmingham, AL |
| 2011-2012 | Clinical Internship, Surgery, Morehouse School of Medicine/Grady Memorial Hospital, Atlanta, GA |
| 2009-2011 | Research Fellowship, Boston University Medical Center, Boston, MA |
| 2006-2007 | Clinical Internship, Gandhi Hospital, Secunderabad |
Board Certifications
| 2019 | American Board of Radiology |
| 2018 | Certified in Clinical Densitometry by The International Society of Clinical Densitometry |
| 2015 | American Board of Nuclear Medicine |
| 2015 | American Board of Medical Quality |
Experience & Service
Academic Appointments
Chief Resident, The University of Alabama at Birmingham, Birmingham, AL, 2014 - 2015
Administrative Appointments/Responsibilities
Patient Safety and Quality Officer, Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present
Other Appointments/Responsibilities
Nuclear Medicine Expert Representative, ACR Appropriate Criteria (AC), Reston, VA, 2019 - Present
Grant, Committee Chair, SNMMI AHRQ (Agency for Healthcare Research and Quality), Reston, VA, 2019 - Present
Member of Reference Committee III, American College of Radiology (ACR), Reston, VA, 2016 - Present
National Quality Scholarship & Mentorship Program Director, American College of Medical Quality (ACMQ), Bethesda, MD, 2015 - 2016
Quality Committee, Society of Nuclear Medicine and Molecular Imaging (SNMMI), Reston, VA, 2015 - 2018
Prostate Cancer-Disease Focused Panel, Society of Abdominal Radiology, Houston, TX, 2000 - Present
Institutional Committee Activities
Member, Theranostics Taskforce, 2021 - 2021
Member, Academic Leadership Team, 2020 - Present
Honors & Awards
| 2023 - 2024 | Council of Early Career Investigators in Imaging, The Academy for Radiology & Biomedical Imaging Research |
| 2019 | AUR Academic Faculty Development Program, Association of University Radiologists |
| 2019 - 2020 | RSNA/ASNR Comparative Effectiveness Research Training (CERT) Program, Chicago, RSNA |
| 2018 | ACR-AUR Research Scholar Program, ACR-AUR |
| 2017 | First Prize, Resident Poster, Oral Presentation, Oklahoma State Radiological Society Annual Meeting |
| 2017 | Trainee Stipend Award, ISMRM/SNMMI PET/MRI Workshop |
| 2017 | RSNA Student Travel Award, RSNA |
| 2017 - 2018 | 2018 Roentgen Resident/Fellow Research Award, RSNA R&E Foundation |
| 2016 | Radiology Leadership Institute Summit Scholarship (September 8-11, 2016), American College of Radiology (ACR) |
| 2015 | SNMMI Future Leaders Academy Program (January 20-21, 2015), SNMMI Future Leaders Academy Program |
| 2015 | National Quality Scholarship Award Program (March 26-28, 2015), American College of Medical Quality (ACMQ) |
| 2015 - 2016 | Stephen Amis, Jr., MD Fellowship in Quality and Safety, American College of Radiology (ACR) |
| 2015 - 2016 | Roentgen Resident/Fellow Research Award, RSNA R&E Foundation |
| 2014 - 2015 | UAB Chief Quality Resident Program |
| 2014 - 2015 | "Eva Dubovsky" Molecular Imaging and Therapeutics Scholar Award for Academic Excellence, University of Alabama at Birmingham |
| 2012 | Best Resident/Basic Scientist Trainee Paper, Second Prize |
| 2011 | Certificate of Merit, RSNA 2011 |
| 2010 | Cum Laude Award, RSNA |
| 2010 | Certificate of Merit, ARRS 2010 |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Bommekal S, Flynt L, Tewari SO, Surasi DS. PSMA-Avid Desmoid Tumor of the Abdominal Wall on 18 F-Piflufolastat PET/CT. Clin Nucl Med 49(7):672-673, 2024. e-Pub 2024. PMID: 38739529.
- Hahn AW, Surasi DS, Viscuse PV, Bathala TK, Wiele AJ, Campbell MT, Zurita AJ, Shah AY, Jonasch E, Gao J, Goswami S, Alhalabi O, Rao P, Sircar K, Tannir NM, Msaouel P. Treatment Outcomes in Patients With Metastatic Renal Cell Carcinoma With Sarcomatoid and/or Rhabdoid Dedifferentiation After Progression on Immune Checkpoint Therapy. Oncologist 29(5):392-399, 2024. PMID: 38035767.
- Raptis CA, Goldstein A, Henry TS, Porter KK, Catenacci D, Kelly AM, Kuzniewski CT, Lai AR, Lee E, Long JM, Martin MD, Morris MF, Sandler KL, Sirajuddin A, Surasi DS, Wallace GW, Kamel IR, Donnelly EF. ACR Appropriateness Criteria® Staging and Follow-Up of Esophageal Cancer. J Am Coll Radiol 19(11S):S462-S472, 2022. PMID: 36436970.
- Thomas JM, Chang EY, Ha AS, Bartolotta RJ, Bucknor MD, Caracciolo JT, Chen KC, Flug J, Kumaravel M, Raizman NM, Ross AB, Silvis ML, Surasi DS, Beaman FD. ACR Appropriateness Criteria® Chronic Elbow Pain. J Am Coll Radiol 19(11S):S256-S265, 2022. PMID: 36436956.
- Yadav D, Hwang H, Qiao W, Upadhyay R, Chapin BF, Tang C, Aparicio A, Lopez-Olivo MA, Kang SK, Macapinlac HA, Bathala TK, Surasi DS. 18F-Fluciclovine versus PSMA PET Imaging in Primary Tumor Detection during Initial Staging of High-Risk Prostate Cancer: A Systematic Review and Meta-Analysis. Radiol Imaging Cancer 4(2):e210091, 2022. PMID: 35212559.
- Surasi DS, Lin L, Ravizzini G, Wong F. Supraclavicular and Axillary Lymphadenopathy Induced by COVID-19 Vaccination on 18F-Fluorthanatrace, 68Ga-DOTATATE, and 18F-Fluciclovine PET/CT. Clin Nucl Med 47(2):195-196, 2022. PMID: 34507331.
- Teyateeti A, Mahvash A, Long J, Abdelsalam M, Avritscher R, Kaseb A, Odisio B, Ravizzini G, Surasi D, Teyateeti A, Macapinlac H, Kappadath SC. Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib. World J Gastroenterol 27(47):8166-8181, 2021. PMID: 35068861.
- Shapiro DD, Soeung M, Perelli L, Dondossola E, Surasi DS, Tripathi DN, Bertocchio JP, Carbone F, Starbuck MW, Van Alstine ML, Rao P, Katz MHG, Parker NH, Shah AY, Carugo A, Heffernan TP, Schadler KL, Logothetis C, Walker CL, Wood CG, Karam JA, Draetta GF, Tannir NM, Genovese G, Msaouel P. Association of High-Intensity Exercise with Renal Medullary Carcinoma in Individuals with Sickle Cell Trait: Clinical Observations and Experimental Animal Studies. Cancers (Basel) 13(23), 2021. e-Pub 2021. PMID: 34885132.
- Guirguis MS, Adrada BE, Surasi DS, Dryden MJ. 68Ga-DOTATATE Uptake in Primary Breast Cancer. Clin Nucl Med 46(3):248-249, 2021. PMID: 33234932.
- Gregg JR, Surasi DS, Childs A, Moll N, Ward JF, Kim J, Daniel CR, Logothetis C, Bathala T, Davis JW. The Association of Periprostatic Fat and Grade Group Progression in Men with Localized Prostate Cancer on Active Surveillance. J Urol 205(1):122-128, 2021. e-Pub 2020. PMID: 32718204.
- Surasi DS, O'Malley JP, Bhambhvani P. 18F-FDG PET/CT Findings in Portal Vein Thrombosis and Liver Metastases. J Nucl Med Technol 43(3):229-30, 2015. e-Pub 2015. PMID: 25655342.
- Surasi DS, O'Malley J, Bhambhvani P. 99mTc-Tilmanocept: A Novel Molecular Agent for Lymphatic Mapping and Sentinel Lymph Node Localization. J Nucl Med Technol 43(2):87-91, 2015. e-Pub 2015. PMID: 25956693.
- Surasi DS, Manapragada P, Bhambhvani P. Lung perfusion imaging in hepatopulmonary syndrome using (99m)Tc macroaggregated albumin. J Nucl Cardiol 22(3):586-8, 2015. PMID: 25164140.
- Surasi DS, Manapragada PP, Lloyd SG, Bhambhvani P. Role of multimodality imaging including Thallium-201 myocardial perfusion imaging in the diagnosis and monitoring of treatment response in cardiac sarcoidosis. J Nucl Cardiol 21(4):849-52, 2014. e-Pub 2014. PMID: 24493414.
- Marcus C, Whitworth PW, Surasi DS, Pai SI, Subramaniam RM. PET/CT in the management of thyroid cancers. AJR Am J Roentgenol 202(6):1316-29, 2014. PMID: 24848831.
- Surasi DS, Bhambhvani P, Baldwin JA, Almodovar SE, O'Malley JP. ¹8F-FDG PET and PET/CT patient preparation: a review of the literature. J Nucl Med Technol 42(1):5-13, 2014. e-Pub 2014. PMID: 24503347.
- Surasi DS, Peller PJ, Szabo Z, Mercier G, Subramaniam RM. Dopamine Transporter SPECT Imaging in Parkinson Disease and Dementia. PET Clin 8(4):459-67, 2013. e-Pub 2013. PMID: 27156473.
- Surasi DS, Lam S, Subramaniam RM. F-18 FDG PET/CT imaging of a hidradenocarcinoma of head and neck. Clin Nucl Med 36(10):945-7, 2011. PMID: 21892057.
- Davison JM, Subramaniam RM, Surasi DS, Cooley T, Mercier G, Peller PJ. FDG PET/CT in patients with HIV. AJR Am J Roentgenol 197(2):284-94, 2011. PMID: 21785073.
- Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of primary hepatobiliary tumors, Part 2. AJR Am J Roentgenol 197(2):W260-5, 2011. PMID: 21785051.
- Sacks A, Peller PJ, Surasi DS, Chatburn L, Mercier G, Subramaniam RM. Value of PET/CT in the management of liver metastases, Part 1. AJR Am J Roentgenol 197(2):W256-9, 2011. PMID: 21785050.
- Surasi DS, Meibom S, Grillone G, Subramaniam RM. F-18 FDG PET/CT imaging of a parapharyngeal hemangioma. Clin Nucl Med 35(8):612-3, 2010. PMID: 20631514.
Other Articles
- Surasi DS, Cornwell B, Hughes J. Cavernous Sinus thrombosis. AJNR Classic case, 2018.
Abstracts
- Palot Manzil FF, Hinshelwood J, Manapragada P, Surasi DS, O'Malley J, Bhambhvani P, Baldwin J, Almodovar S. The role of Y90 sphere therapies in the treatment of hepatic malignancies. J Nucl Med. Meeting Abstracts 54(supplement 2):1286, 2013.
- Mercier G, Surasi DS. Kinetic analysis of gastric pouch emptying after bariatric surgery. J Nucl Med. Meeting Abstracts 52(supplement 1):1360, 2011.
- Subramaniam R, Surasi DS, Mercier G. Tumor metabolic volume and total glycolytic activity and outcome in patients with breast cancer. J Nucl Med. Meeting Abstracts 52(supplement 1):1809, 2011.
- Davison JM, Surasi DS, Cooley T, Subramaniam RM. The value of FDG-PET/CT in the management of HIV-related malignancies. Electronic exhibit at ARRS. Awarded Certificate of Merit, 2010.
Book Chapters
- Subramaniam RM, Davison JM, Surasi DS, Jackson T, Cooley T.. Patients with HIV. In: PET/CT and PET/MRI in Oncology. 1st Edition. Springer, 379-398, 2012.
- Subramaniam RM, Davison JM, Surasi DS, Russo G, Peller PJ. Chest. In: PET/CT and PET/MRI in Oncology. 1st Edition. Springer, 77-100, 2012.
- Surasi DS, Sacks A, Davison J, Agarwal A, Mehta A, Ryan T, Filitis D, Subramaniam R. Chapter 13: PET/CT (9 cases). In: Head and Neck Imaging Cases. McGraw-Hill, 2011.
- Aparicio A, Pilie P, Surasi DS, Choi S, Chapin B, Logothetis C, Corn P. Neoplasms of the prostate. In: Holland-Frei Cancer Medicine. 10th Edition. Wiley-Blackwell.
Grant & Contract Support
| Date: | 2022 - Present |
| Title: | An Evidence-Based Focal Cryotherapy Protocol for Focal Ablation of Intermediate Risk Prostate Cancer (IIT) |
| Funding Source: | The University of Texas MD Anderson Cancer Center PRIME Funding |
| Role: | Collaborator |
| ID: | 2022-0165 |
Patient Reviews
CV information above last modified August 20, 2024